Cynosure Group’s Keysight KEYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$682K Sell
1,949
-1,794
-48% -$612K 0.1% 97
2026
Q1
$1.06M Hold
3,743
0.13% 52
2025
Q4
$761K Sell
3,743
-2,878
-43% -$534K 0.08% 91
2025
Q3
$1.16M Sell
6,621
-6,936
-51% -$1.16M 0.13% 62
2025
Q2
$2.22M Buy
13,557
+11,190
+473% +$1.71M 0.25% 46
2025
Q1
$355K Buy
2,367
+348
+17% +$57.5K 0.05% 216
2024
Q4
$324K Sell
2,019
-541
-21% -$87.2K 0.05% 182
2024
Q3
$407K Sell
2,560
-11,195
-81% -$1.59M 0.06% 200
2024
Q2
$1.88M Buy
13,755
+11,597
+537% +$1.69M 0.3% 49
2024
Q1
$337K Sell
2,158
-26,716
-93% -$4.11M 0.06% 184
2023
Q4
$4.59M Buy
28,874
+1,971
+7% +$268K 0.83% 24
2023
Q3
$3.56M Buy
26,903
+8,755
+48% +$1.3M 1.09% 26
2023
Q2
$3.04M Buy
18,148
+7,335
+68% +$1.14M 0.91% 34
2023
Q1
$1.75M Sell
10,813
-3,922
-27% -$666K 2.64% 12
2022
Q4
$2.52M Sell
14,735
-553
-4% -$94.3K 2.61% 10
2022
Q3
$2.41M Hold
15,288
2.58% 10
2022
Q2
$2.11M Buy
15,288
+109
+0.7% +$15.5K 2.07% 13
2022
Q1
$2.4M Buy
+15,179
New +$2.53M 1.93% 15

Other funds holding KEYS

Cynosure Group's KEYS Position: Q2 2026 in Review

Cynosure Group reduced its Keysight (KEYS) stake by 48% in Q2 2026, selling an estimated $612K and leaving 1,949 shares worth $682K. The position accounts for 0.1% of the portfolio, ranked #97.

Cynosure Group first reported a position in KEYS in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.59M in Q4 2023. 1,255 funds tracked by Wall St. Rank hold KEYS as of Q2 2026.

  • Cynosure Group held 1,949 shares of Keysight worth $682K as of Q2 2026.
  • Cynosure Group sold 1,794 Keysight shares in Q2 2026, an estimated $612K.
  • Keysight made up 0.1% of Cynosure Group's portfolio in Q2 2026, its #97 holding.
  • Cynosure Group first reported a position in Keysight in Q1 2022 and has held it in 18 quarters since.
  • Cynosure Group's Keysight position peaked at $4.59M in Q4 2023.
  • 1,255 funds tracked by Wall St. Rank held Keysight as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.